ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

DRUG Stock Ownership Breakdown

NASDAQ : DRUG

Bright Minds Biosciences Inc.

$33.11

1.1+3.44%

At Close 4:00 PM

59.32

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

DRUG Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares1.41

Short Percent Of Float2.08

Shares Outstanding7.04M

Shares Float2.52M

Shares Short99.65K

Short Ratio2.57

2.08%

Short % of Float

1.41%

Short % of Shares Outstanding

Market Insider DRUG

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

27.28% Percentage of Shares held by All Insiders

44.28% Percentage of Shares held by All Institutions

60.89% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 44.28% of DRUG shares are held by financial institutions. CHECCHI CAPITAL ADVISERS, LLC is the top corporate investor, holding 14.14K shares valued at $8.06K. A 0.07% stake in Bright Minds Biosciences Inc. is owned by the company. BLACKROCK INC. owns 11.8K shares valued at $6.73K, which translates its holding of 0.06% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Jun 30, 2023	CHECCHI CAPITAL ADVISERS, LLC	0.07%	14.14K	8.06K	0	0
Jun 30, 2023	BLACKROCK INC.	0.06%	11.8K	6.73K	0	0
Jun 30, 2023	RENAISSANCE TECHNOLOGIES LLC	0.06%	11.2K	6K	-16.5K	-59.57%
Jun 30, 2023	ADVISORSHARES INVESTMENTS LLC	2.72%	515.32K	293.78K	66.16K	+14.73%
Jun 30, 2023	TWO SIGMA SECURITIES, LLC	0.09%	16.72K	9.53K	16.72K	+100.00%
Jun 30, 2023	ROYAL BANK OF CANADA	0.01%	2.41K	1K	332	+15.95%
Jun 30, 2023	UBS GROUP AG	0.01%	2.1K	1.2K	-8.8K	-80.75%
Jun 30, 2023	SIMPLICITY SOLUTIONS, LLC	0%	0	-	-46.2K	-100.00%
Jun 30, 2023	QUATTRO FINANCIAL ADVISORS LLC	0%	0	-	-21.15K	-100.00%
Jun 30, 2023	ASPIRE PRIVATE CAPITAL, LLC	0%	0	-	-500	-100.00%

DRUG Insiders

Among the DRUG insiders holding of 27.28% of the stake in company, CORMORANT ASSET MANAGEMENT, LP, 10 percent owner, holds the largest shares of 1.06M. , , is the second largest DRUG insider with ownership of - shares. , , stands third with possession of - shares of that stake.

Insiders	Designation	Shares Held
CORMORANT ASSET MANAGEMENT, LP	10 percent owner	1.06M

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 04, 2024	CORMORANT ASSET MANAGEMENT, LP	PURCHASE	21.70	184.33K	4M	1.06M
Oct 16, 2024	CORMORANT ASSET MANAGEMENT, LP	PURCHASE	23.21	39.74K	922.63K	864.74K
Oct 15, 2024	CORMORANT ASSET MANAGEMENT, LP	PURCHASE	4.53	238.1K	1.08M	690.51K

Insider Transaction Summary (6 Months)

SHARESTRANS

PURCHASE184.33K1

SALES00

NET SHARES184.33K1

SHARES HELD1.06M1

% NET SHARES-82.6%0%

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.